Glenmark initiates Phase 3 clinical trials on antiviral Favipiravir for COVID-19 patients in India
365telugu.com, online news, Mumbai, 13th May 2020: Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company has initiated Phase 3 clinical trials in India on Antiviral tablet Favipiravir, for which it…